The University of Cambridge fight over Cambridge Blue
In a recent decision, the UK Intellectual Property Office found in favour of Cambridge University and upheld an opposition against a trade mark application for CAMBRIDGE BLUE.
Exhaustion regime post-Brexit – A new UK consultation
The Brexit transition period came to an end on 31 December 2020 and as of 1 January 2021 the UK was no longer bound by EU legal framework. Before the UK left the EU, the UK was party to the EU’s regional exhaustion of IP rights regime.
Is it worth patenting your AI tools for drug discovery?
Often, when the AI identifies a drug, and experiments confirm it is useful for the intended purpose, the drug can be patented. But what about the AI itself – can the AI be protected by patents, and should you try to?
The Greenshoots Podcast by Appleyard Lees – episode 16: the entrepreneurial journey of Mags Walker, founder of the fabl and Toolally.
Serial entrepreneur Mags Walker joins Appleyard Lees partner and solicitor Chris Hoole to talk about
Someone’s copying my invention! What should I do?
What do you do if, before you have obtained a granted patent, a third party starts selling a product that looks like your invention? Is there anything you can do to stop the third party? Does your patent application provide you with any rights before the patent is granted? Parminder Lally and Simon Ambroz answer these questions.
Real-world rules apply to patenting computer simulations
It is possible to patent computer-implemented inventions at the European Patent Office (EPO). In particular, it is possible to patent computer-implemented inventions (CIIs) which function in the real-world.